Neurosyphilis Clinical Trial
Official title:
Retro-prospective Multicentric Study Aiming to Evaluate the Benefit of Measuring an Intrathecal Synthesis Index of Specific Antitreponema IgG for Patients Suspected of Neurosyphilis
Verified date | November 2023 |
Source | University Hospital, Geneva |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
A retro-prospective case-control Swiss study was conducted to evaluate the diagnostic performance of measuring an antibody index (AI) for intrathecal synthesis of specific anti-Treponema pallidum (T. pallidum) IgG for the diagnosis of neurosyphilis.
Status | Completed |
Enrollment | 181 |
Est. completion date | December 31, 2022 |
Est. primary completion date | December 31, 2022 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - All patients who have serum / CSF sample pairs collected concomitantly (3 days maximum interval between blood test and lumbar puncture). - Age > or = 18 years old. Exclusion Criteria: - All patients for whom the stored samples do not meet the needs of the diagnostic study, or whose serum and CSF collection date is more than 3 consecutive days. - Age < 18 years old. - No written consent form for the prospective part. |
Country | Name | City | State |
---|---|---|---|
Switzerland | Laurence Toutous Trellu | Geneva |
Lead Sponsor | Collaborator |
---|---|
University Hospital, Geneva | Swiss HIV Cohort Study, Swiss National Science Foundation |
Switzerland,
Alberto C, Deffert C, Lambeng N, Breville G, Gayet-Ageron A, Lalive P, Toutous Trellu L, Fontao L. Intrathecal Synthesis Index of Specific Anti-Treponema IgG: a New Tool for the Diagnosis of Neurosyphilis. Microbiol Spectr. 2022 Feb 23;10(1):e0147721. doi: 10.1128/spectrum.01477-21. Epub 2022 Feb 9. — View Citation
Reiber H, Peter JB. Cerebrospinal fluid analysis: disease-related data patterns and evaluation programs. J Neurol Sci. 2001 Mar 1;184(2):101-22. doi: 10.1016/s0022-510x(00)00501-3. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Evaluation of the diagnostic performance of measuring an antibody index (AI) for intrathecal synthesis of specific anti-Treponema pallidum IgG for the diagnosis of neurosyphilis. | AI testing measured with an Elisa specific for anti-Treponema pallidum IgG for all patients : number of patients with positive AI, sensitivity/specificity of the test, and positive/negative predictive values of AI test were estimated. | 2020-2022 with retrospective samples from 2007 to 2019 and prospective samples from 2019 to 2022. | |
Secondary | Intrathecal oligoclonal IgG production analysis | IgG oligoclonal bands were analysed in CSF and serum of NS and control patients by the gold standard isoelectric focusing method | 2020-2022 with retrospective samples from 2007 to 2019 and prospective samples from 2019 to 2022. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01589289 -
Rapid Diagnostic Tests and Clinical/Laboratory Predictors of Tropical Diseases in Neurological Disorders in DRC
|
Phase 3 | |
Recruiting |
NCT03418441 -
Central Nervous System Infections in Denmark
|
||
Completed |
NCT00000648 -
A Pilot Study Evaluating Penicillin G and Ceftriaxone as Therapies for Presumed Neurosyphilis in HIV Seropositive Individuals
|
N/A |